19 "inflammatory bowel diseases" clinical trials found.
-
A Multicenter Randomized Double-Blind Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn s Disease
The purpose of this study is to assess an investigational drug called etrasimod (also referred to as the “study drug”) in the treatment of Crohn ... -
Induction Optimization with Stelara for Crohn s Disease
The purpose of this study is to compare the effectiveness of a second weight based dose of Stelara given intravenously to the standard dose administered ... -
A Randomized Double-Blind Placebo-Controlled. Multi-center Proof-of-Mechanism Phase 2a Study to Evaluate the Safety Tolerability and efficacy of TAK-018 (EB8018) for the Prevention of Post-Operative Crohn s Disease Recurrence.
The main purpose of this study is to evaluate how safe and tolerable a drug called TAK-018 (or sibofimloc,the “Takeda Study Drug”) is in ... -
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial
The purpose of this study is to find out if using a computer program (called iDose) to guide infliximab dosing is more effective and safer ... -
A Phase 2 Randomized Double-Blind Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease
The purpose of this research study is to measure how effective and how safe BMS-986165 is in treating study participants with moderate to severe Crohn ... -
Monitoring and Prediction of Treatment Response in Crohn s Disease with Dual-Energy CT Enterography
The purpose of this study is to prospectively evaluate the use of dual-energy CT enterography (DECTE) obtained iodine density and iodine density maps to monitor ... -
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Inflammatory Bowel Diseases (IBD) are treated with many different medications, none of which are 100% effective. One of the challenges of treating IBD is to ... -
A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
We want to know the safety and tolerability of the anti-programmed death 1 (PD-1) antibody nivolumab at different dose levels for patients with autoimmune disorders ... -
Serologic Testing and Genomic Analysis of Autoimmune ImmuneMediated and Rheumatic Patients with COVID-19 (SAGA)
The purpose of this study is to obtain blood samples and nasal swab samples of patients with autoimmune and inflammatory diseases to see if certain ...